Search hospitals > Minnesota > Virginia

Essentia Health Virginia Clinic

Claim this profile
Virginia, Minnesota 55792
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
121 reported clinical trials
2 medical researchers
Photo of Essentia Health Virginia Clinic in VirginiaPhoto of Essentia Health Virginia Clinic in Virginia

Summary

Essentia Health Virginia Clinic is a medical facility located in Virginia, Minnesota. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Essentia Health Virginia Clinic is involved with conducting 121 clinical trials across 309 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.

Area of expertise

1Thyroid Cancer
Global Leader
Essentia Health Virginia Clinic has run 52 trials for Thyroid Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Essentia Health Virginia Clinic has run 31 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
HER2 positive

Top PIs

Clinical Trials running at Essentia Health Virginia Clinic

Breast Cancer
Lung Cancer
Thyroid Cancer
Ovarian Cancer
Cancer
Breast cancer
Bladder Cancer
Kidney Cancer
Stomach Cancer
Skin Cancer
Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Essentia Health Virginia Clinic?
Essentia Health Virginia Clinic is a medical facility located in Virginia, Minnesota. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Essentia Health Virginia Clinic is involved with conducting 121 clinical trials across 309 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security